DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

12.39 -0.41 (-3.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

OSIR $12.39 -3.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.75
Previous Close $12.80
Daily Range $12.33 - $13.03
52-Week Range $10.00 - $27.40
Market Cap $424.0M
P/E Ratio -309.75
Dividend (Yield) $0.00 (0.0%)
Volume 272,435
Average Daily Volume 276,410
Current FY EPS -$0.25

Sector

Healthcare

Industry

Drugs

Osiris Therapeutics, Inc. (OSIR) Description

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. Website: http://www.osiristx.com/

News & Commentary Rss Feed

3 Ways 3-D Bioprinting Can Disrupt the Health-Care Industry

Will 3-D bioprinting technology from companies such as Organovo disrupt older technologies from Boston Scientific, Osiris Therapeutics, and Hanger?

Osiris Therapeutics Inc. Stock Downgraded (OSIR)

Osiris Therapeutics Inc. Stock Downgraded (OSIR)

Osiris Misses on Q4 Earnings - Analyst Blog

Osiris Therapeutics CEO Discusses Q4 2013 Results - Earnings Call Transcript

Osiris Therapeutics, Inc. Discusses Q3 2013 Results (Webcast)

Athersys: Two Crucial Near-Term Events

Could PCT Be NeoStem's Breakout Star?

Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Resea

Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease

Vital Stem Cell Data And Development Coming In 2014

See More OSIR News...

OSIR's Top Competitors

OSIR $12.39 (-3.20%)
Current stock: OSIR
AMGN $115.46 (-0.07%)
Current stock: AMGN
GILD $70.00 (1.04%)
Current stock: GILD
BIIB $290.54 (-0.32%)
Current stock: BIIB